InvestorsHub Logo
Followers 37
Posts 21090
Boards Moderated 1
Alias Born 07/10/2015

Re: blue_skies post# 19989

Tuesday, 09/25/2018 2:12:06 AM

Tuesday, September 25, 2018 2:12:06 AM

Post# of 41891
BS, Amda did not get a loan. They received a promissary note from CTL. That will be booked as an asset.

8m cash
6m note
1.5m long term earn out

Their liabilities will be nill as CTL takes over royalties and commission, so maybe 2m at best. They will also have derivative liabilities but those are not real liabilities.

Current implant technology is toxic with Cobalt Chromium being the worse in terms of systemic issues.

Amedica's business model is fine but they do need other revenue sources to help fund R&D. This can be easily accomplished with a licensing deal in Dental.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News